Ron H. N. van Schaik

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · The Lancet · 2014 · 1.6K citations · Full text

Medicine, Oncology, Urology +13

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. Schumacher, Ali Amin Al Olama, Sonja I. Berndt et al. · Nature Genetics · 2018 · 1K citations · Full text

Life Sciences, Genetics, Oncology +14

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

William J. Catàlona, Alan W. Partin, Martin G. Sanda et al. · The Journal of Urology · 2011 · 493 citations · Full text

Medicine, Oncology, Urology +15

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 419 citations · Full text

Medicine, Oncology, Pharmacology +16

The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

Stacy Loeb, Martin G. Sanda, Dennis L. Broyles et al. · The Journal of Urology · 2014 · 294 citations · Full text

Medicine, Oncology, Urology +17